Axiom Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Axiom Investment Management's PFE Position: Q2 2026 in Review
Axiom Investment Management increased its Pfizer (PFE) stake by 695% in Q2 2026, buying an estimated $1.97M and bringing the position to 86,053 shares worth $2.07M. The position accounts for 1.38% of the portfolio, ranked #18.
Axiom Investment Management first reported a position in PFE in Q4 2018 and has held it in 19 quarters since. The position peaked at $10M in Q4 2018. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Axiom Investment Management held 86,053 shares of Pfizer worth $2.07M as of Q2 2026.
- Axiom Investment Management bought 75,231 Pfizer shares in Q2 2026, an estimated $1.97M.
- Pfizer made up 1.38% of Axiom Investment Management's portfolio in Q2 2026, its #18 holding.
- Axiom Investment Management first reported a position in Pfizer in Q4 2018 and has held it in 19 quarters since.
- Axiom Investment Management's Pfizer position peaked at $10M in Q4 2018.
- 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.